glp 1 drugs online GLP-1 advertising overstates benefits and underplays risks Comparing Ozempic, Wegovy and Other
Description
But with innovation comes risk
Carris NW et al
Early, in-depth review article that evaluates the similarities and differences between short-acting and long-acting GLP-1R agonists in terms of glucose-lowering efficacy and adverse effects, and discusses the possibilities for utilizing these agents for individualized treatment of T2DM
Biomolecules 2022;12:1580.ArticlePubMedPMC 16
A.ChanM.DesaiA
